Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


suck pdf from google scholar
unlimited free pdf from europmc32353597    free
PDF from PMC    free
html from PMC    free
PDF vom PMID32353597  :  Publisher
PDF vom PMID32353597 :   free
PDF vom PMID32353597

suck abstract from ncbi

Nephropedia Template TP Text

Twit Text FOAVip

Twit Text #

English Wikipedia

  • Severe Acute Respiratory Syndrome-Coronavirus-2 Infection and Patients With Lung Cancer: The Potential Role of Interleukin-17 Target Therapy #MMPMID32353597
  • Cafarotti S
  • J Thorac Oncol 2020[Jul]; 15 (7): e101-e103 PMID32353597show ga
  • The coronavirus disease 2019 outbreak is evolving rapidly worldwide. The lungs are the target of the primary infection and patients with lung cancer seem to have a poor prognosis. To our knowledge, this is the first reported investigation of a possible role of interleukin-17 target therapy in patients with lung cancer and concomitant severe acute respiratory syndrome-coronavirus-2 infection.
  • |*Betacoronavirus/drug effects/physiology[MESH]
  • |*Coronavirus Infections/drug therapy/immunology[MESH]
  • |*Interleukin-17/antagonists & inhibitors/immunology[MESH]
  • |*Lung Neoplasms/drug therapy/immunology[MESH]
  • |*Pandemics[MESH]
  • |*Pneumonia, Viral/drug therapy/immunology[MESH]
  • |*Respiratory Distress Syndrome/drug therapy/immunology[MESH]
  • |COVID-19[MESH]
  • |Chemokines, CXC/metabolism[MESH]
  • |Drug Discovery[MESH]
  • |Humans[MESH]
  • |Inflammation/immunology[MESH]
  • |Molecular Targeted Therapy/methods[MESH]
  • |SARS-CoV-2[MESH]
  • |Th17 Cells/immunology[MESH]
  • |Up-Regulation/drug effects[MESH]

  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    e101 7.15 2020